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Abstract
Background—Uptake of HPV vaccine remains low among adolescents in the United States. We 
sought to assess barriers to HPV vaccine provision in school health centers to inform subsequent 
interventions.
Methods—We conducted structured interviews in Fall 2010 with staff from all 33 school health 
centers in North Carolina that stocked HPV vaccine.
Results—Centers had heterogeneous policies and procedures. Out-of-pocket costs for children to 
receive privately-purchased HPV vaccine were a key barrier to providing HPV vaccine within 
school health centers. Other barriers included students not returning consent forms, costs to clinics 
of ordering and stocking privately-purchased HPV vaccine, and difficulty using the statewide 
immunization registry. Most (82%) school health centers were interested in hosting interventions 
to increase HPV vaccine uptake, especially those that the centers could implement themselves, but 
many had limited staff to support such efforts. Activities rated as more likely to raise HPV vaccine 
uptake were student incentives, parent reminders, and obtaining consent from parents while they 
are at school (all p < .05).
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Conclusions—While school health centers reported facing several key barriers to providing 
HPV vaccine, many were interested in partnering with outside organizations on low-cost 
interventions to increase HPV vaccine uptake among adolescent students.
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Human papillomavirus (HPV) causes almost all cervical cancers and a significant portion of 
vulvar, vaginal, penile, anal, and oropharyngeal cancers.1 Two vaccines protecting against 
HPV infection could prevent the majority of these HPV-associated cancers.2,3 Current 
guidelines from the Advisory Committee on Immunization Practices recommend routine 
administration of HPV vaccine to adolescents ages 11 or 12, with catch-up vaccination 
appropriate through age 21 for young men and age 26 for young women.4 However, 
coverage remains low, with only 53.0% of girls and 8.3% of boys ages 13 through 17 
receiving at least one dose of the three-dose HPV vaccine series, and series completion is 
even lower at 34.8% and 1.3%, respectively.5
A potentially feasible and effective way to increase HPV vaccine coverage is through in-
school vaccination programs. School-located programs offering voluntary HPV vaccination 
free of charge in countries such as the United Kingdom and Australia have achieved 
completion rates that exceed 80%.6–11 Indeed, HPV vaccine series completion is highest 
when provided in school settings.12 One option is mass vaccination programs that bring 
temporary vaccination clinics to schools, but these have been only moderately successful in 
the U.S. in improving vaccine uptake for the seasonal flu shot,13–15 tetanus, diphtheria, and 
pertussis booster,16 varicella vaccine,17 or HPV vaccine.18 For example, the median increase 
in HPV vaccine coverage from mass vaccination programs is 10%.19
An alternative is to use health centers that are linked to or located within schools. School 
health centers are associated with increased rates of adolescent vaccination,20,21 especially 
for adolescents who are under- or uninsured20,22 or those who interact less frequently with 
more traditional healthcare venues.23 Both parents24 and physicians25 have favorable 
attitudes towards vaccination at school sites, and most school health centers (84%) already 
have the refrigeration equipment, staff, and billing systems to provide adolescent 
vaccines.22,26 However, school health centers often focus on basic health services rather 
than more resource-intensive preventive health services, such as vaccines,27 and expanding 
school health centers’ services requires local commitment in terms of budget and health 
priorities.28 Improving interventions aimed at delivering vaccines through existing school 
health centers in the United States could boost support for school health centers as well as 
increase rates of HPV vaccine initiation and completion.
Our study aimed to better understand HPV vaccination services in school health centers and 
to identify barriers to their providing the vaccine. We also sought to assess the viability of 
potential interventions to increase HPV vaccine provision in these centers. These results can 
guide future interventions to increase HPV vaccination rates at school health centers.
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We interviewed representatives from school health centers in North Carolina that stocked 
HPV vaccine. The North Carolina School Community Health Alliance, a statewide 
organization that supports the work of school health centers, provided us with contact 
information for all 53 school health centers in NC and emailed our study recruitment letter 
to representatives at each center. School health centers were eligible for the study if they (1) 
were school-based (located on a school campus) or school-linked (located off-campus but 
serving students from designated schools) and (2) offered HPV vaccine. We excluded school 
health centers that did not stock HPV vaccine because our study aimed to focus specifically 
on barriers to maintaining, rather than establishing, an HPV vaccination program.
Twenty school health centers in NC were ineligible to participate in this study. Nine of these 
centers did not offer any vaccine services, and eight offered other vaccines but not HPV 
vaccine. The remaining three school health centers were ineligible because they did not 
serve students in the targeted age range for HPV vaccine.
Sixteen organizations coordinated the 33 eligible school health centers, and representatives 
from all of these organizations completed interviews in fall 2010, yielding a response rate of 
100%. Respondents were school health center administrators (N = 13) or another person 
designated by the administrator as more knowledgeable about the topics on the survey (N = 
2 nurse practitioners and 1 physician). Seven participants represented only one school health 
center, while the remaining nine participants represented organizations that coordinated 
more than one school health center; for these latter participants, we completed separate 
interviews in reference to each eligible school health center that the participant coordinated. 
We entered each of the 33 participating school health centers into a drawing for one of two 
unrestricted $500 donations.
Procedure
Interviewers used a structured telephone questionnaire that focused on school health center 
vaccination services and procedures, barriers to providing HPV vaccine, and potential 
interventions for increasing vaccine uptake (questionnaire available at www.unc.edu/
~ntbrewer/hpv.htm). Interviewers made case notes that we verified using audio recordings 
of the interviews. The institutional review board of the University of North Carolina 
approved the study protocol.
Measures
The questionnaire assessed existing procedures and services, including standard operations 
of the center (eg, hours, whether the center accepts private insurance); if centers stocked 
publicly- or privately-funded HPV vaccine; successes and challenges to providing HPV 
vaccine; use of the North Carolina Immunization Registry (NCIR), a centralized electronic 
health record database containing information on children’s and adolescents’ immunization 
history; tracking and reminders (eg, postcards or automated phone calls) to students who 
initiate HPV vaccination; costs and reimbursements for HPV vaccine; and procedures for 
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obtaining parent and/or student consent for HPV vaccination. Questions about barriers to 
providing HPV vaccine to students measured respondents’ concerns about obtaining medical 
records, costs to school health centers, costs to parents, and interference from school 
administration. Respondents could report on all of their perceived barriers, and we also 
asked them to identify area(s) of greatest concern.
Finally, we asked participants to rate several activities to increase uptake of HPV vaccine in 
terms of effectiveness, 1 (“would not increase uptake a lot”) to 3 (“would increase uptake a 
lot”); feasibility, 1 (“not very doable”) to 3 (“very doable); and helpfulness, 1 (“not very 
helpful”) to 3 (“very helpful”). Activities included those led by school health centers (eg, 
sending parents letters endorsing adolescent vaccines; student-led promotional campaigns; 
and student incentives for vaccination) and those led by outside parties (eg, adding school 
health centers to networks of approved providers for private insurance plans; developing 
new consent forms that appeal to parents; and addressing HPV vaccine in health education 
classes). We also asked respondents more general questions about HPV vaccination 
activities, such as staff availability to implement interventions and their interest in partnering 
with outside organizations to conduct the new activities.
Data Analysis
We report descriptive quantitative data around several topics from the surveys, including the 
number and percentage of respondents reporting a given outcome. For quantitative data, the 
denominator for percentages is 33, unless stated otherwise. We compared intervention 
ratings using either t-tests or analysis of variance, with post-hoc t-tests, as appropriate. We 
used SPSS version 18 (SPSS Inc., Chicago, IL) to perform two-tailed statistical analyses 
with a critical alpha of .05. These comparisons allowed us to evaluate which potential 
interventions were particularly attractive to school health center administrators, in terms of 
their perceived effectiveness, feasibility, and helpfulness.
We examined qualitative data from open-ended questions for common themes. Two coders 
independently evaluated the open-ended responses and discussed discrepancies as they arose 
to reach a final consensus.
RESULTS
Characteristics of School Health Centers
The 33 school health centers served schools with approximately 28,000 students in grades 6 
or higher (mean = 863/school, standard deviation [SD] = 757, range = 24–3600) (Table 1). 
Centers’ average proportion of Spanish-speaking students served was 11% (SD = 14%, 
range = 0%–50%). Most (91%) of the centers were located on school premises, and 42% 
were in rural areas.
All of the school health centers accepted both public and private health insurance, although 
some centers (33%) did not accept all types of private insurance (Table 1). All of the school 
health centers stocked publicly-purchased vaccines (ie, purchased by the Vaccines for 
Children [VFC] program), and 55% stocked privately-purchased vaccines.
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To track adolescent vaccines delivered to students, school health centers used the NCIR 
(33%) and other methods (91%) (Table 1). To document HPV vaccination, 70% used 
electronic health records besides NCIR. All of the school health centers stocked quadrivalent 
HPV vaccine, but none stocked bivalent HPV vaccine. In the 2009–2010 school year, 
centers delivered an average of 57 doses of HPV vaccine (SD = 93, range = 0–436) (N = 27 
centers reporting), and an average of 6 students received all three doses of HPV vaccine at 
each clinic (SD = 9, range = 0–26) (N = 13 centers reporting).
School Health Center Policies for Adolescent Vaccination
School health centers employed a wide variety of policies to manage adolescent vaccination. 
Below, we summarize the policies related to consent and cost.
Consent procedures—All of the school health centers sought written parental consent to 
provide health services to students, but a few (18%) also accepted verbal parental consent 
(Table 2). Most centers (76%) required additional consent forms from parents before 
administration of adolescent vaccines. Most often, this separate consent form was a vaccine 
checklist that included HPV vaccine and other adolescent vaccines, although two centers 
required a separate consent form for each adolescent vaccine. Most (55%) of the centers 
required parental consent for HPV vaccine for students of all ages.
Cost—For students receiving adolescent vaccines through VFC, the average fee charged to 
the family for administering one dose of HPV vaccine was $10 (SD = $7, range = $0-$18) 
(Table 2). Because costs for HPV vaccine for students with private insurance vary, we did 
not collect data on out-of-pocket costs for privately-purchased vaccines.
Barriers to HPV Vaccination
Students—More than three-quarters (79%) of school health centers cited out-of-pocket 
costs for students to receive privately-purchased HPV vaccine as a barrier to vaccination, 
and 51% cited this issue as the most important barrier (Table 3). Many (33%) school health 
centers also reported that out-of-pocket costs for students to receive VFC-purchased HPV 
vaccine were a barrier to vaccination. Few respondents indicated that parental attitudes 
towards HPV vaccine (18%) or parental knowledge about HPV (3%) were barriers to 
students’ receiving permission to receive HPV vaccine.
School health centers—The most commonly-cited barrier to HPV vaccination for 
school health centers was students not returning consent forms (76%) (Table 3). Many 
respondents also identified barriers such as upfront costs of stocking privately-purchased 
HPV vaccine (67%) and inadequate reimbursement from insurance companies for 
administering privately-purchased HPV vaccine (42%).
Several barriers to HPV vaccination revolved around difficulties with tracking students’ 
immunizations and maintaining accurate health records. Many (61%) school health centers 
stated that obtaining students’ immunization history was a barrier to vaccination (Table 3). 
Although all of the school health centers used NCIR, many centers (76%) reported in open-
ended responses that they had difficulty using this system, including slow operating systems, 
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effort involved in double-entry of data into both the Registry and internal records, and need 
for additional training to use the Registry.
Finally, few school health centers (21%) rated school administrators’ concern about 
students’ time away from classes as a barrier to providing HPV vaccine (Table 3). One 
center reported that a school administrator expressed concern that the vaccination clinics 
might draw the school into the public discussion over HPV vaccine.
Activities to Increase HPV Vaccination
Most (82%) school health centers were somewhat or very interested in taking part in 
activities to increase HPV vaccine uptake. However, 67% reported that limited staff affected 
their ability to implement new activities, and few respondents thought that teaching staff 
would be willing to assist with HPV vaccine interventions (21%). Therefore, centers were 
most interested in activities that did not require a lot of effort from center staff.
Current activities—Many centers already engaged in interventions to increase HPV 
vaccination among students. Notably, 82% of centers sent reminders to parents when 
students were due for adolescent vaccines (Figure 1). Fewer centers mailed parents letters 
endorsing adolescent vaccines (42%) or obtained consent for vaccination from parents while 
they were physically at the school (eg, at parent-teacher conferences) (37%).
New activities—Most (79%) school health centers reported that they were interested in 
taking part in new activities to promote HPV vaccination. Respondents’ open-ended 
responses reflected enthusiasm for receiving HPV vaccine brochures or posters specifically-
tailored for adolescents, although they would prefer promotional materials about multiple 
adolescent vaccines over materials that only focused on HPV vaccine. Other activities 
suggested by respondents in open-ended responses included media campaigns for parents of 
boys, parent education campaigns, literature with photos of genital warts and cervical 
cancer, subsidization of out-of-pocket vaccine costs, health fairs, expert forums, mass 
immunization events, and dissemination of information on evidence-based practices that 
have been successful in other school health centers.
Among new activities that school health centers would lead, respondents rated student 
incentives for vaccination and sending parents letters endorsing adolescent vaccines as more 
feasible than the remaining activities (post-hoc t-test comparing these 2 interventions to 
remaining 3 school-led activities, p < .005) (Table 4). When asked to rate whether activities 
would increase HPV vaccine uptake, respondents gave higher marks to student incentives 
for vaccination, sending parents reminders when students are due for adolescent vaccines, 
and obtaining consent from parents while they are at the school than they did to the 
remaining activities (post-hoc t-test comparing these 3 interventions to remaining 3 school-
led activities, p < .05).
Respondents rated the new activities that outside organizations would lead as similarly 
helpful (ANOVA comparing 6 activities, p = .82) and similarly likely to increase HPV 
vaccine uptake (ANOVA comparing 6 activities, p = .50) (Table 4). Respondents rated 
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school health center-led activities as more likely to increase vaccine uptake than activities 
led by outside parties (t-test comparing the two types of activities, p = .008).
DISCUSSION
Although school health centers have a wide variety of policies regarding student 
vaccination, parental consent, and private insurance, almost all school health centers said 
that cost to parents and centers of stocking and administering HPV vaccine hinders 
immunization efforts. School health centers were interested in interventions that would 
address these and other barriers to HPV vaccination, especially interventions that are low-
cost, easy to implement, and implemented by the centers. Below, we highlight several 
themes from the interviews with administrators of school health centers in North Carolina 
and discuss their implications for interventions efforts aimed at increasing HPV vaccination.
Consistent with other research,29–31 we found that costs associated with HPV vaccine, both 
for the school health centers and for the families of students, were a significant barrier to 
provision. The costs of privately-purchased HPV vaccine were particularly problematic in 
terms of both the upfront costs for school health centers to stock the vaccine and the out-of-
pocket costs for students to receive the vaccine. Even theoretically nominal out-of-pocket 
administration fees for VFC-purchased vaccines were a barrier, suggesting that federal laws 
requiring providers to waive administration fees for VFC-eligible individuals who could not 
afford them are not enough to entirely address this problem. Interviews with physicians have 
identified similar cost-related barriers to providing HPV vaccine.31,32 Cost barriers offer 
multiple points of intervention, though they may require more resources than school health 
centers are able to provide. It remains to be seen how policy changes, such as the Affordable 
Care Act, will affect the provision of vaccines in school health centers; however, we know 
that policy interventions are likely to have the biggest impact on public health.33
Another major challenge facing school health centers is parental consent for HPV vaccine. 
Future interventions could focus on encouraging parents to consent to HPV vaccination 
delivered at school health centers. Better consent tracking systems or revised consent forms 
offer an opportunity for a sustainable change in practice that may increase uptake of HPV 
and other adolescent vaccines. Another option is opt-out consent, which has increased 
participation in a variety of health services in other contexts in the U.S.34–36 Alternatively, 
two school health centers reported that they did not require parental consent for HPV 
vaccine due to the North Carolina confidential services law that allows provision of certain 
health services without parental consent.37 Eliminating the requirement for parental consent, 
or establishing a younger age at which parental consent is no longer necessary, would reduce 
some barriers to HPV vaccine provision.
Characteristics of school health centers also represent challenges for future interventions. 
The school health centers in our study were heterogeneous in terms of size, location, 
organizational structure, and populations served. The impact of future interventions could 
vary greatly between centers; therefore, interventions should be easily adaptable for varied 
settings. In addition, school health centers varied widely in terms of stocking and providing 
HPV vaccine. The most successful school health center delivered more than 400 HPV doses 
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in the 2009–2010 school year, yet fully one-third of school health centers in North Carolina 
were ineligible for this study because they did not even stock HPV vaccine (despite 
anecdotal reports from school health center experts indicating that all centers in North 
Carolina offered HPV vaccine). Indeed, as of spring 2012, most of the participating school 
health centers (14 out of 28 school-located health centers who we obtained data for) had 
stopped stocking HPV vaccine. Future research is needed to address what prevents school 
health centers from providing HPV vaccine.
School health centers also reported difficulties with the centralized North Carolina 
Immunization Registry. All of the centers used the Registry to record vaccination, but many 
respondents noted barriers with using this resource in addition to internal tracking 
procedures as well as with obtaining students’ vaccine histories. These complexities may 
reflect the need for improved tracking systems or additional NCIR user training. More 
specifically, adolescent vaccine efforts could be greatly improved by systems that link the 
records of school health centers with those of other providers. Ideally, these infrastructure 
changes would support school health centers in their vaccination efforts and improve the 
health of student populations.
Several of these barriers could generalize to school health centers’ provision of other 
recommended adolescent vaccines (tetanus, diphtheria, and pertussis booster and 
meningococcal conjugate4), particularly the difficulties with tracking or recordkeeping. 
Previous research has demonstrated that parents report similarly high levels of consent for 
vaccination in school health centers for all three adolescent vaccines.38
Limitations
Our study did not gather data on parents’ beliefs and attitudes about interventions to increase 
HPV vaccine uptake in school health centers, a topic that merits further 
investigation.19,24,36,39 We also did not collect data on some contextual factors that might 
influence intervention success, such as the school health center enrollment rate and whether 
the centers call students out of class for vaccine-only visits or offer the vaccine only when 
students come into the clinic for other health needs. In addition, future studies should 
investigate further the impact of out-of-pocket costs, for both privately- and publicly-
purchased vaccines, especially given the many uncertainties surrounding the implementation 
of the Affordable Care Act. At the time of this study, North Carolina’s VFC funding only 
supported vaccination for under- and uninsured children (ie, not universal coverage of all 
children regardless of insurance status), which could limit the generalizability of these 
findings to states with public funding for vaccination for VFC-only individuals. Finally, our 
sample was limited to school health centers stocking HPV vaccine in North Carolina, and 
the generalizability of our results to centers in other states will depend on the respective 
healthcare and policy environments.
Conclusions
We viewed school health centers as an opportunity to better understand how to deliver HPV 
vaccine in schools, and lessons learned from these existing programs may be applicable to 
mass vaccination clinics and other school-based efforts to vaccinate adolescents. If schools 
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are to be viable as alternative sites for HPV vaccination, developing a multi-pronged 
approach is critical because at present, relatively few schools have school-located health 
centers. North Carolina has 2,524 schools, including 1,835 schools that serve students in 
pre-kindergarten through eighth grade,40 capturing the targeted age range for HPV vaccine, 
11 to 12 years. Only 2.9% (53/1,835) of these schools had access to a school-located or 
school-linked health center, and only 1.8% (33/1,835) had a health center that stocked HPV 
vaccine. Across the country, only 6% of schools have affiliated health centers.27 Improving 
access to school-located health centers may help increase adolescent vaccination, but mass 
vaccination programs in schools without these health centers will remain a necessity for 
school-located vaccination to have a broad impact.
Our study used quantitative and qualitative data to investigate currently existing policies and 
procedures in all of the school health centers in North Carolina that stocked HPV vaccine. In 
addition, we measured their interest in and perceptions of potential new activities to increase 
students’ uptake of HPV vaccine. These results provide evidence that school health centers 
face significant challenges to delivering HPV vaccine, particularly around parental consent 
and vaccine costs. However, the school health center administrators reported a high level of 
interest in activities to increase vaccination, including strategies that they implemented 
themselves or that involved outside partners.
Public health professionals identifying intervention strategies to implement in school health 
centers should consider multiple, interacting points of intervention. Figure 2 indicates 
several potential interventions to address barriers to HPV vaccination in school health 
centers, from the configuration of the clinic, through enrollment and consent processes, to 
initiation and completion of the vaccine series. All of these interventions exist in the context 
of local and national policies and priorities that enable or hinder the efforts of school health 
centers to improve HPV vaccination.28 While we have identified several specific 
intervention strategies, we recognize that these interventions address barriers that exist in 
complex medical and social environments and are not independent of each other. For 
example, a school health center intervention to improve adolescent vaccine consent rates 
will not dramatically increase uptake of HPV vaccine at a school where few students have 
enrolled in the school health center. Likewise, an intervention targeting improved consent 
rates will not necessarily translate into increased uptake of HPV vaccine if a school health 
center does not have the resources to collect students’ immunization histories or schedule 
vaccine visits.
IMPLICATIONS FOR SCHOOL HEALTH
Our study illustrates the potential of school health centers as natural sites for interventions to 
increase HPV vaccination, based on the centers’ current vaccine promotion activities and 
barriers to providing HPV vaccine. Our findings indicate that cost, parental consent, and 
recordkeeping demands limit the ability of school health centers to offer HPV vaccine. 
Nevertheless, school health centers are willing to lead and to partner on interventions to 
boost uptake of HPV vaccine. Given the low rate of HPV vaccination in the United States 
and the success of school-based vaccination programs in other countries, interventions at 
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school health centers represent important, underutilized tools that could have valuable public 
health impact.
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Table 1
Characteristics of School Health Centers, North Carolina (N = 33).
%
Students enrolled in associated school, mean (SD) (N = 26) 863 (757)
Percentage of Spanish-speaking students, mean (SD) 11% (.14)








 Most school days 97%
 Limited hours 3%
Accept all types of private insurance
 Yes 67%
 No 33%






Use North Carolina Immunization Registry (NCIR) to update students’ electronic health records
 Yes 100%
 No 0%
Use reminder/recall function of NCIR to track students who initiate vaccination
 Yes 33%
 No 67%
Use other methods to track students who initiate vaccination
 Yes 91%
 No 9%
Partner with outside organizations to provide HPV vaccine
 Yes 46%
 No 55%
Use electronic records of HPV vaccination
 Yes 70%
 No 30%
HPV vaccine product stocked
 Quadrivalent 100%
 Bivalent 0%
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%
HPV vaccine doses administered in 2009–2010 school year, mean (SD 57 (93)
Number of students receiving all 3 doses of HPV vaccine in 2009–2010 school year, mean (SD) 6 (9)
Note. School-located clinics were located on premises while school-linked were located offsite.
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Table 2
School Health Center Vaccination Policies (N = 33).
%
Mode of consent for vaccination
 In writing 100
 Verbally 18
Separate consent form required for adolescent vaccination
 Yes 76
 No 24
Characteristics of separate consent form for adolescent vaccination (N = 25)
 Checklist of all adolescent vaccines 76
 Separate consent form for each adolescent vaccine 8
 Separate consent form only for HPV vaccine 8
 Verbal consent for adolescent vaccines 8
Parent consent required to give HPV vaccine if younger than… (N = 31)
 16 years 3
 18 years 29
 21 years 13
 all ages 55
Cost of VFC-supported HPV vaccine administration, mean (SD) $10 (7)
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Table 4
Activities to Increase HPV Vaccination at School Health Centers, North Carolina (N = 33).
Activities led by school health centers Feasible (mean) Would increase uptake (mean)
Obtain consent for vaccination from parents while they are at school† 1.7 2.3 b
Mail parents letters endorsing adolescent vaccines† 2.4 a 2.0
Send reminders to parents when students are due for adolescent vaccines† -- 2.4 b
Have student-led promotional campaigns 2.1 2.0
Host school-based HPV vaccine awareness raising events 2.0 2.2
Give student incentives for receiving adolescent vaccines 2.8 a 2.5 b
Activities led by outside parties Helpful (mean) Would increase uptake (mean)
Provide additional training to use NCIR 2.1 1.9
Pay for privately-purchased doses of HPV vaccine after administration 2.0 2.0
Add school health centers to private insurance plans’ approved providers 2.2 2.1
Develop new consent forms that appeal to parents 2.1 2.0
Give additional HPV vaccine brochures or posters 2.1 2.1
Address HPV vaccine in health education classes 2.1 2.0
Note. Response scales had 3 options (ie, “not at all doable” to “very doable”; “would increase uptake not at all” to “would increase uptake a lot”; or 
“would help not at all” to “would help a lot”).
†
Does not include clinics already engaging in these activities.
a
These two activities had higher ratings for “Feasibility” that the remaining 3 school-led activities, based on post-hoc t-tests.
b
These three activities had higher ratings for “Would increase uptake” than the remaining 3 school-led activities, based on post-hoc t-tests.
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